Dimensional Fund Advisors
STOK icon

Dimensional Fund Advisors’s Stoke Therapeutics STOK Stock Holding History

Dimensional Fund Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.2M Buy
989,936
+162,797
+20% +$5.34M 0.01% 1731
2025
Q4 		$26.3M Buy
827,139
+148,832
+22% +$4.47M 0.01% 1846
2025
Q3 		$15.9M Buy
678,307
+4,423
+0.7% +$75.8K ﹤0.01% 2106
2025
Q2 		$7.65M Buy
673,884
+9,149
+1% +$86.9K ﹤0.01% 2375
2025
Q1 		$4.42M Buy
664,735
+125,835
+23% +$1.17M ﹤0.01% 2531
2024
Q4 		$5.94M Buy
538,900
+273,890
+103% +$3.36M ﹤0.01% 2486
2024
Q3 		$3.26M Buy
265,010
+73,650
+38% +$1.04M ﹤0.01% 2660
2024
Q2 		$2.58M Sell
191,360
-28,405
-13% -$384K ﹤0.01% 2698
2024
Q1 		$2.97M Buy
219,765
+4,471
+2% +$27.1K ﹤0.01% 2692
2023
Q4 		$1.13M Sell
215,294
-43,128
-17% -$184K ﹤0.01% 2905
2023
Q3 		$1.02M Sell
258,422
-81,723
-24% -$537K ﹤0.01% 2924
2023
Q2 		$3.62M Buy
340,145
+46,513
+16% +$495K ﹤0.01% 2622
2023
Q1 		$2.45M Buy
293,632
+1,625
+0.6% +$14.7K ﹤0.01% 2694
2022
Q4 		$2.69K Sell
292,007
-46,989
-14% -$489K ﹤0.01% 2642
2022
Q3 		$4.35M Buy
338,996
+73,975
+28% +$1.18M ﹤0.01% 2476
2022
Q2 		$3.5M Buy
265,021
+113,361
+75% +$1.72M ﹤0.01% 2560
2022
Q1 		$3.19M Buy
151,660
+79,518
+110% +$1.59M ﹤0.01% 2682
2021
Q4 		$1.73M Buy
72,142
+27,423
+61% +$654K ﹤0.01% 2884
2021
Q3 		$1.14M Sell
44,719
-60,664
-58% -$1.69M ﹤0.01% 3018
2021
Q2 		$3.55M Sell
105,383
-3,440
-3% -$122K ﹤0.01% 2705
2021
Q1 		$4.22M Buy
108,823
+69,010
+173% +$3.93M ﹤0.01% 2633
2020
Q4 		$2.46M Buy
39,813
+32,432
+439% +$1.49M ﹤0.01% 2751
2020
Q3 		$247K Buy
+7,381
New +$211K ﹤0.01% 3181

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Dimensional Fund Advisors's STOK Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Stoke Therapeutics (STOK) stake by 20% in Q1 2026, buying an estimated $5.34M and bringing the position to 989,936 shares worth $32.2M. The position accounts for 0.01% of the portfolio, ranked #1731.

Dimensional Fund Advisors first reported a position in STOK in Q3 2020 and has held it in 23 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Dimensional Fund Advisors held 989,936 shares of Stoke Therapeutics worth $32.2M as of Q1 2026.
  • Dimensional Fund Advisors bought 162,797 Stoke Therapeutics shares in Q1 2026, an estimated $5.34M.
  • Stoke Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1731 holding.
  • Dimensional Fund Advisors first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.